Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Revisão |
| Jezik: | angleščina |
| Izdano: |
2020
|
| Online dostop: | https://doi.org/10.1080/14737159.2020.1768849 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Komentirajte kot prvi!